The pharmaceutical and biotech company recently combined its HR and IT departments under a single leader in a move that has ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

In a crucial development, the FDA has approved Moderna's new COVID-19 vaccine designed specifically for high-risk Americans.

In a precedential decision issued June 4, 2025, the U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed a district ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Moderna had already started a Phase 1/2 trial of its bird flu (H5N1) vaccine and reported strong early results.

Brad Miller as president of CoreAI. Based in Seattle, Miller will lead the company's CoreAI business and its Deep Enterprise AI platform. He joins Keystone from Moderna, where he served as chief ...

People on low-calorie diets scored higher for symptoms of depression, compared with those not dieting, researchers reported.

Over the past 15 months, the U.S. Centers for Disease Control and Prevention has confirmed 70 human cases of bird flu across ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

Children born to women who are obese have a higher risk of landing in a hospital with a severe infection, a new study says.